Jungang Vaccine Reports Operating Profit of 2.042 Billion KRW in Q2, Up 504.1% Year-on-Year
[Asia Economy Reporter Oh Ju-yeon] Jungang Vaccine announced on the 22nd that its operating profit for the second quarter of this year increased by 504.1% compared to the same period last year, reaching 2.042 billion KRW. Sales rose by 22.8% to 10.422 billion KRW, and net profit turned positive to 2.091 billion KRW.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- "Is It Possible to Look That Happy at Work? Of Course They're Smiling" SK hynix Employees' Expressions Go Viral
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
